{'fraction_non_alphanumeric': 0.028089887640449437, 'fraction_numerical': 0.007022471910112359, 'mean_word_length': 5.0423728813559325, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A retrospective review of factors associated with response to phototherapy and PUVA for atopic eczema

There is randomised study evidence that narrowband ultraviolet B (NB-UVB) is effective for eczema. A small controlled study did not detect an efficacy difference between bath 8-MOP PUVA (psoralen drug with the main effects limited to the skin as the drug is 'activated' there by ultraviolet A [UVA] exposure) and NB-UVB. Another small randomised study showed that 5-MOP oral PUVA worked better than medium-dose ultraviolet A1 (UVA1). A systematic review concluded that NB-UVB and ultraviolet A1 were the most effective phototherapies for eczema and pointed out the limited comparative evidence regarding PUVA.